The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.

Including the name of the #1 company to buy.

Christopher J. O'Connell net worth and biography

Christopher O'Connell Biography and Net Worth

CEO of Waters

Christopher J. O'Connell has been appointed as Chairman of the Board of the Company effective 9/1/2020. when he assumed the position of President and Chief Executive Officer of the Company. In December 2017, Mr. O’Connell was appointed as the Chairman of the Board of Directors of the Company. Mr. O’Connell served as Executive Vice President and President of Restorative Therapies Group of Medtronic plc from August 2009 to August 2015. From 1994 to August 2009, Mr. O’Connell served in the following positions at Medtronic plc: Senior Vice President and President of Medtronic Diabetes, President of Medtronic Physio-Control, Vice President of Sales and Marketing for the Cardiac Rhythm Management business, Vice President/General Manager of the Patient Management Business, Vice President of Corporate Strategy, Director of Investor Relations and Corporate Development Associate. Mr. O’Connell has over 24 years of progressive leadership positions. Prior to Waters, he provided overall strategic direction and operational management of the Medtronic’s Restorative Therapies Group’s five divisions, as well as led the integration of the Group’s activities within the overall strategy of the corporation.

What is Christopher J. O'Connell's net worth?: The estimated net worth of Christopher J. O'Connell is at least $21.12 million as of July 31st, 2020. Mr. O'Connell owns 57,595 shares of Waters stock worth more than $21,117,783 as of November 21st. This net worth estimate does not reflect any other assets that Mr. O'Connell may own. Learn More about Christopher J. O'Connell's net worth.
How do I contact Christopher J. O'Connell?: The corporate mailing address for Mr. O'Connell and other Waters executives is 34 MAPLE STREET, MILFORD MA, 01757. Waters can also be reached via phone at (508) 478-2000 and via email at [email protected]. Learn More on Christopher J. O'Connell's contact information.
Has Christopher J. O'Connell been buying or selling shares of Waters?: Christopher J. O'Connell has not been actively trading shares of Waters during the past quarter. Most recently, Christopher J. Oconnell sold 30,000 shares of the business's stock in a transaction on Friday, July 31st. The shares were sold at an average price of $213.30, for a transaction totalling $6,399,000.00. Following the completion of the sale, the chief executive officer now directly owns 57,595 shares of the company's stock, valued at $12,285,013.50. Learn More on Christopher J. O'Connell's trading history.
Who are Waters' active insiders?: Waters' insider roster includes Linda Baddour (Director), Michael Berendt (Director), Sherry Buck (Former CFO), Robert Carson (SVP), Edward Conard (Director), Richard Fearon (Director), Michael Harrington (SVP), Ian King (SVP), Christopher Kuebler (Director), Christopher O'Connell (CEO), JoAnn Reed (Director), Thomas Salice (Director), and Mark Vergnano (Director). Learn More on Waters' active insiders.
Are insiders buying or selling shares of Waters?: During the last twelve months, Waters insiders bought shares 1 times. They purchased a total of 1,000 shares worth more than $332,900.00. During the last twelve months, insiders at the medical instruments supplier sold shares 2 times. They sold a total of 4,500 shares worth more than $1,624,330.00. The most recent insider tranaction occured on May, 28th when Director Richard H Fearon bought 1,000 shares worth more than $332,900.00. Insiders at Waters own 0.8% of the company. Learn More about insider trades at Waters.
Information on this page was last updated on 5/28/2024.

Christopher J. O'Connell Insider Trading History at Waters

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
7/31/2020	Sell	30,000	$213.30	$6,399,000.00	57,595

Christopher J. O'Connell Buying and Selling Activity at Waters

Waters Company Overview

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.

Today's Range

Now: $366.66

$357.41

$368.01

50 Day Range

MA: $352.17

$322.08

$387.34

2 Week Range

Now: $366.66

$273.60

$393.38

Volume

259,237 shs

Average Volume

435,594 shs

Market Capitalization

$21.77 billion

P/E Ratio

34.99

Dividend Yield

N/A

Beta

0.97

Financial Prophecy

From Porter & Company | Ad